Phase
Startup
Starfish of Sweden
Starfish of Sweden has developed a platform to shield patients from conditions known to lead to pressure ulcers, a painful condition that is difficult to treat. Starfish of Sweden is developing a broad product portfolio, ready for the market needs of the future.
Johan Johansson joined Starfish of Sweden as CEO beginning of 2023, with the goal to take the patent to a CE marked product. He has several years of experience working with Medical Device and has an M.Sc. in Electronic Engineering from the University of Lund.
Did you know?
The technical design of the Starfish concept provides improved dermal circulation and also minimizes heat and moisture concentrations – the three main factors known to contribute to the development of pressure ulcers. The material does not conduct heat, is washable, tolerates fluid accumulations, has high fire safety, longer durability and is developed from a sustainable perspective.
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Cell factories for dairy processing
Automated microscopy image acquisition and analysis
Implants of magnesium alloys
Digital service for patients
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Digital assistive device for post-surgical rehabilitation
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
Effective treatments for brain tumors
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
